Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Letters|July 31, 2015
Superoxide induces protein oxidation in plasma and TNF-α elevation in macrophage culture: Insights into mechanisms of neurotoxicity following doxorubicin chemotherapyJeriel T R Keeney, Sumitra Miriyala, Teresa Noel, et al.The American Journal of Pathology|November 30, 2011
Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer arrayGeoffrey S Baird, Sally K Nelson, Tracy R Keeney, et al.Neurotoxicity Research|November 16, 2011
Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer diseaseJeriel T R Keeney, Aaron M Swomley, Jessica L Harris, et al.Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)|November 16, 2019
A Prospective Clinical Study on Implant Survival at 1-Year Post-Loading of a Bone-Level Tapered Implant in Private Practice: Multicentered StudyRobert A Levine, Bradley S McAllister, Robert J Miller, et al.Free Radical Biology & Medicine|December 30, 2018
The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-αXiaojia Ren, Jeriel T R Keeney, Sumitra Miriyala, et al.Free Radical Biology & Medicine|July 23, 2013
Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive declineJeriel T R Keeney, Sarah Förster, Rukhsana Sultana, et al.The New England Journal of Medicine|April 21, 1983
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjectsY J Bryson, M Dillon, M Lovett, et al.Plos One|October 25, 2011
From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assayStephan Kraemer, Jonathan D Vaught, Christopher Bock, et al.Oncotarget|August 14, 2018
Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment ("chemobrain")Jeriel T R Keeney, Xiaojia Ren, Govind Warrier, et al.Plos One|April 25, 2015
Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical StudyJohn Hayslip, Emily V Dressler, Heidi Weiss, et al.Pageof 3